BC
FLNA

Broadfin Capital’s Filana Therapeutics FLNA Stock Holding History

Broadfin Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-111,429
Closed -$4.29M – 76
2014
Q1 		$4.29M Sell
111,429
-64,285
-37% -$2.27M 0.42% 58
2013
Q4 		$5.98M Buy
175,714
+32,857
+23% +$872K 0.79% 38
2013
Q3 		$2.72M Hold
142,857
– – 0.48% 44
2013
Q2 		$2.21M Buy
+142,857
New +$3.02M 0.43% 42

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital's FLNA Position: Q2 2014 in Review

Broadfin Capital sold out of Filana Therapeutics (FLNA) in Q2 2014, closing a stake of 111,429 shares — an estimated $4.29M sold.

Broadfin Capital first reported a position in FLNA in Q2 2013 and held it in 4 quarters. The position peaked at $5.98M in Q4 2013. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2014.

  • Broadfin Capital reported no remaining Filana Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Broadfin Capital sold 111,429 Filana Therapeutics shares in Q2 2014, an estimated $4.29M.
  • Broadfin Capital first reported a position in Filana Therapeutics in Q2 2013 and held it in 4 quarters.
  • Broadfin Capital's Filana Therapeutics position peaked at $5.98M in Q4 2013.
  • 87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2014.

Based on Broadfin Capital's 13F filing for Q2 2014, filed 14 Aug 2014.